Fentanyl is commonly used as an adjunct to general anaesthesia for day-surgery procedures. We have prospectively studied the effect of this practice on postoperative analgesia in 304 day-surgery patients, 164 undergoing termination of pregnancy and 140 having various other minor gynaecological procedures. Approximately half the patients received fentanyl, the mean dose being 50 mcg. Fentanyl given during anaesthesia had no effect during recovery on analgesic requirements or on nausea or vomiting in either pregnant or non-pregnant patients.
Short-acting opioids such as fentanyl are often used in day-surgery procedures as an adjunct to inhalational anaesthesia. Although it has been reported that fentanyl prolongs the action of propofol, no practical advantage during surgery was found to be conferred by this technique. 1 It is also widely believed that the use of fentanyl during anaesthesia provides significant analgesia in the immediate postoperative period, and this belief is the subject of the present study.
We have prospectively evaluated the effect of this common anaesthetic practice on postanaesthetic analgesic requirements and nausea and vomiting in a large group of female day-surgery patients having minor procedures. Pregnant and non-pregnant patients were separately analysed.
PATIENTS AND METHODS All patients given inhalational anaesthesia for minor gynaecological procedures in day-surgery during a three-month period were prospectively studied. Anaesthetists included third or fourth year registrars-in-training, sessional anaesthetists and full-time staff anaesthetists. The anaesthetic to be administered was chosen by the anaesthetist concerned, and no attempt was made by the investigators to influence the routine anaesthetic practice employed.
This group of patients was chosen for study because it was large, could be reliably documented and was likely to receive a relatively consistent anaesthetic technique (apart from the use or not of fentanyl). The two subgroups, pregnant and nonpregnant, were separately analysed because, while each was considered reasonably homogeneous, they could differ between them in the end-points under study. Because of this within-subgroup homogeneity, because all assessments were independent and because of the nature of the population being studied, a randomised, doubleblind design which would normally be chosen was felt in this instance to be neither necessary nor feasible.
The patient demographics and anaesthetic details were obtained from the routine hospital record. Postoperative nausea, vomiting, anti emetic administration and analgesic requirements were recorded by the recovery room nursing staff using a predesigned survey form.
RESULTS
There were 304 ASA Class I or 11 patients during the study period; 164 patients (54%) presented for termination of pregnancy and 140 non-pregnant patients (46%) presented for other minor gynaecological procedures (57 for diagnostic dilatation and curettage of the uterus (0 and C), 62 for colposcopy, biopsy of the cervix, 0 and C and diathermy of the cervix, and 21 for miscellaneous procedures).
Pregnant patients
Ninety-one patients (55%) were given fentanyl (1 mcglkg IV) and 73 (45%) were not given fentanyl at induction of anaesthesia (Table 1 ). The median dose of fentanyl was 50 mcg (range 25-100 mcg).
The mean age overall was 26 years (range 17 to 45 years), with no statistical difference between the fentanyl and non-fentanyl groups.
The induction agents used were propofol (154 patients, 94%) and methohexitone (10 patients, 6%), with no statistically significant difference in choice of agent between the two groups ( Table 1) . The doses used were 150-250 mg of propofol and 60-100 mg of methohexitone.
Anaesthesia was maintained with nitrous oxide (70-75%)/oxygen, either with (113 patients, 69%) or without (51 patients, 31 %) supplementary volatile agents (Table 1) . A statistically significantly greater proportion in the non-fentanyl group received volatile agents (89% v. 53%), in particular enflurane. Those patients in the non-fentanyl group who did not receive volatile agents (11 %) were given incremental doses of the induction agent, a commonly used technique for short procedures such as termination of pregnancy which always takes less than ten minutes and often less than five minutes.
About half of the patients required postoperative analgesia, virtually all being given oral analgesics, either paracetamol with codeine (71 patients) or aspirin with codeine (4 patients). Ony one patient was given intramuscular pethidine. There was no statistically significant difference in the analgesic requirements between the fentanyl and nonfentanyl groups (Table 1) .
Although nearly twice as many patients in the fentanyl group complained of nausea and twice as many vomited, these differences were not statistically significant, since the number of patients overall who suffered nausea with or without vomiting was small (9%) ( Table 1) . More patients were nauseated (12% v. 6%) and more patients vomited (8% v. 3%) in the group receiving postoperative analgesics compared with the group not receiving analgesics, but these differences were not statistically significant. Nausea and vomiting usually occurred in the immediate postoperative period, before any oral analgesic administration. This observation suggested that patients experiencing pain were more likely to be nauseated and to vomit.
Non-pregnant patients
Eighty-two patients (59%) were given fentanyl (1 mcglkg IV) and 58 (41 %) were not given fentanyl at induction of anaesthesia ( Table 2 ). The median dose offentanyl was 50 rocg (range 25-75 mcg). The mean age overall was 35 years (range 19 to 103 years), with no statistical difference between the fentanyl and non-fentanyl groups.
The induction agents used were propofol (123 patients, 88%), methohexitone (14 patients, 10%) and other (3 patients, 2%), with no statistically significant difference in choice of agent between the two groups ( Table 2 ). The doses used were 150-250 mg for propofol and 60-100 mg for methohexitone.
As with the pregnant patients, anaesthesia was maintained with nitrous oxide (70-75%)/oxygen, either with (107 patients, 76%) or without (33 patients, 24%) supplementary volatile agents ( Table 2) . A statistically significantly greater proportion in the non-fentanyl group received volatile agents (91 % v. 66%), in particular enflurane. Those patients in the non-fentanyl group who did not receive volatile agents (24%) were given incremental doses of the induction agent.
About one third of the patients required postoperative analgesia, all being given oral analgesics in the form of paracetamol with codeine. One patient was given intramuscular pethidine in addition. There was no statistically significant difference in the analgesic requirements between the fentanyl and non-fentanyl groups ( Table 2) .
Although more patients in the fentanyl group complained of nausea and more vomited, these differences were not statistically significant, since the number of patients overall who suffered nausea with or without vomiting was small (4%) ( Table 2 ).
More patients were nauseated (6% v. 2%) and more patients vomited (4% v. 2%) in the group receiving postoperative analgesics compared with the group not receiving analgesics, but these differences were not statistically significant. As with the pregnant patients, nausea and vomiting usually occurred in the immediate postoperative period, before any oral analgesic administration.
DISCUSSION
In the present study, the use of the short-acting opioid, fentanyl, as an adjunct to general anaesthesia for minor surgical procedures, was shown to have no effect on the immediate postoperative analgesic requirements in either pregnant or non-pregnant patients. The lack of observed postoperative analgesia after fentanyl may be related to its rapid clearance. Thus, after an intravenous bolus of 500 mcg of fentanyl, its plasma concentration has been reported to fall below analgesic concentrations within 1 5 minutes. 3 The lack of postoperative analgesia observed in the present study is at variance with the findings of other studies. 4 ,5 However, these differences are likely to be due to the more recent use of improved day-surgery anaesthesia with the advent of propofol for induction and the decreased use of halothane for maintenance of anaesthesia.
Although much larger numbers of patients would be needed for statistical confirmation, it seems possible that fentanyl may increase the incidence of nausea and vomiting in the recovery period. This observation has also been previously reported by others,2 although the incidence of nausea (52-68%) and of vomiting (36-60%) was much higher than in the present study (9% and 5% in pregnant patients and 4% and 3% in non-pregnant patients). This is likely to be due to the substantial differences between the studies in patient population, anaesthetic technique (especially the use of propofol or methohexitone instead of thiopentone) and duration of procedure.
The value of using fentanyl as an adjunct to inhalational anaesthesia for short surgical procedures in day-surgery should be questioned. Since its ability to prolong the action of new shortacting induction agents such as propofol is not of practical value in this situation, I its overall utility and cost-effectiveness are especially doubtful in view of the additional lack of improved postoperative analgesia and the possibility of increased nausea and vomiting following its use.
